Medical Equipment
Meihua International Medical Technologies Co., Ltd. Announces Pricing of $36,000,000 Initial Public Offering
YANGZHOU, China, Feb. 16, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced the pricing of...
2022-02-16 20:34
4657
Nippon Express (China) Donates Protective Suits to China Railway Express Terminal Station in Xi'an
TOKYO, Feb. 16, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a Nippon Express Holdings, Inc. Group company, has donated protective suits to the Xi'an International Inland Port Investment & Development Group (hereinafter "ITL Group") operating the rail terminal i...
2022-02-16 15:00
3383
A Breakthrough in Probiotic Therapy - Personalized Probiotics (Dispensing) Machine for a Balanced and Enhanced Immune System
BANGKOK, Feb. 16, 2022 /PRNewswire/ -- MED-CU has invented a Personalized
Probiotics (Dispensing) Machine to deliver live microorganisms that have health
benefits to treat patients with unclear health problems and those with
microbial imbalances or "dysbiosis".
2022-02-16 10:00
3002
Largest Hospital in Queensland, Australia Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
- Royal Brisbane and Women's Hospital acquisition is intended to expand access to potentially life-saving radiotherapy treatments to more patients - Hospital was the first in Australia to invest in the TomoTherapy® helical radiotherapy delivery platform and is now the first to secure the latest ...
2022-02-15 05:10
5054
Clinical trials in Russia and Azerbaijan demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
MOSCOW, Feb. 14, 2022 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca's vaccine and the first ...
2022-02-14 16:00
3237
Visionflex Chooses Vonage to Power its Next-Generation Remote Healthcare and Diagnostic Services
HOLMDEL, N.J., Feb. 14, 2022 /PRNewswire/ -- Vonage (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, has been chosen byVisionflex to power the future of telehealth and remote diagnostic equipment for medical professionals through th...
2022-02-14 06:32
3425
Zimmer Biomet Opens ZBEdge Customer Experience Centre in Singapore to Drive Robotics and Medical Technology Transformation
SINGAPORE, Feb. 11, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), aglobal medical technology leader, today celebrated the opening of the ZBEdge Customer Experience Centre (CEC), a unique facility located at the company'sAsia Pacific regional headquarters in Singapore. ...
2022-02-11 08:00
8727
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
SEOUL, South Korea, Feb. 10, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, today announced that it has signed a supply deal with the Ministry of Health ofBrazil to deliver four million COVID-19 tests. Since January 2022, Brazil has battled a...
2022-02-10 20:00
3054
GLOBAL HEALTH TECHNOLOGY PLATFORM, PROXIMIE, ANNOUNCES NEW SENIOR APPOINTMENTS, BUILDING ON ITS STRONG START TO 2022
General Manager for the Americas - Charles H. Wilhelm, and Chief Growth Officer -Dave Herrmann, appointed BOSTON, Feb. 10, 2022 /PRNewswire/ -- Proximie, the global health technology platform digitizing operating rooms (OR) around the world, announces the appointments of a General Manager for th...
2022-02-10 20:00
3841
USI Awarded S&P Global Bronze Class in Sustainability Yearbook 2022
SHANGHAI, Feb. 10, 2022 /PRNewswire/ -- USI (SSE: 601231) is pleased to announce the recognition as a S&P Global Bronze Class company in our first invited participation of the S&P Global ESG Index Corporate Sustainability Assessment (CSA). The Sustainability Yearbook 2022 is based on the 2021 CSA...
2022-02-10 07:00
5606
Correction: Year-end report 2021 Bactiguard Holding AB
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- In previous press releases regarding the year-end report for 2021, incorrect information related to "Cash flow from operating activities" has been reported. Correction is made with this press release and the correct PDF is attached for Bactiguard Holding AB...
2022-02-09 22:17
3115
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
SIR-Spheres® Y-90 resin microspheres are the first therapeutic radiopharmaceutical approved by the NMPA in 2022 WOBURN, Mass., Feb. 9, 2022 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceut...
2022-02-09 21:30
2216
Mobile Medical Imaging Systems Improving Care Accessibility and Convenience for Patients
Portability and cost-effectiveness are key factors propelling the adoption of mobile medical imaging technology globally, says Frost & Sullivan SAN ANTONIO, Feb. 9, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the drawbacks of traditional medical imaging platforms are drivin...
2022-02-09 20:00
2016
Bactiguard presents focused growth strategy and sets new long-term financial targets
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least1 billion SEK and annual EBITDA of at least 400 million SEK in...
2022-02-09 07:27
2655
First Proton Therapy Treatment Delivered in Southeast Asia at Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center, Thailand
BANGKOK, Feb. 9, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, today announced that Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center has begun treating patients with its new Varian ProBeam® proton therapy system, the first of its kind inThailand and Southeast Asia. ...
2022-02-09 05:15
5582
IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research
MELBOURNE, Australia, Feb. 7, 2022 /PRNewswire/ -- Premium manufacturer of chromatography for proteomics applications, IonOpticks, has entered an OEM partnership with the Bruker Corporation (Nasdaq: BRKR), allowing Bruker to expand their portfolio of 4D-Proteomics solutions with the release of th...
2022-02-08 00:01
2685
Covaris AFA-energetics™ Enables True Automated Total Nucleic Acid Extraction and Purification Workflows from FFPE Tissues
A fully automated, high-throughput deparaffinization and total Nucleic Acids extraction and purification kit for FFPE samples WOBURN, Mass., Feb. 7, 2022 /PRNewswire/ -- Covaris, LLC ("Covaris" or "the Company"), a manufacturer of advanced tools enabling life science innovations, announced the l...
2022-02-07 23:00
3841
Clarivate Identifies Seven Medtech Trends to Watch in 2022
LONDON, Feb. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report,Outlook on the Medtech Industry: Seven Areas to Watch. The report analyzes seven factors that Clarivate ...
2022-02-07 16:00
2613
Genesis MedTech Acquires JC Medical, Creates New Structural Heart Franchise
SINGAPORE, Feb. 4, 2022 /PRNewswire/ -- Genesis MedTech Group (Genesis or Group) has completed the acquisition of JC Medical (JCM), a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment ...
2022-02-05 08:00
5115
Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms
Cytognos divestment is a first strategic step aimed at positioning Vitro as a
new worldwide diagnostic player in their key market segments
SEVILLE, Spain, Feb. 4, 2022 /PRNewswire/ -- Vitro S.A, (www.vitro.bio
2022-02-04 17:23
5113
Week's Top Stories
Most Reposted
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
[Picked up by 325 media titles]
2026-08-05 11:34
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 296 media titles]
2026-08-04 07:00
Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 295 media titles]
2026-08-06 15:10
Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
[Picked up by 292 media titles]
2026-08-04 14:30
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
[Picked up by 289 media titles]
2026-08-04 06:00
Most Read
Association of Trade and Commerce Reinforces Commitment to Supporting Singapore Enterprises Through Global Growth at The Entrepreneur Singapore 2026
2026-07-31 21:45
22186
CLASSYS Appoints Former Samsung Electronics Executive Vice President Jun-oh Yoon as CEO to Lead Its Next Stage of Global Growth
2026-07-31 23:12
11759
Oxford International Digital Institute Launches Oxford ELLT Express to Support Time-Sensitive Student Applications
2026-07-31 22:57
10790
